Palmitoyl-protein thioesterase-1 in health and disease
- 25 February 2026
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 47 (3) , 248-262
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (2R44NS107079-02A1)
- National Institute of Neurological Disorders and Stroke (1SB1NS135733-01)
This publication has 106 references indexed in Scilit:
- Protein palmitoylation in cancer: molecular functions and therapeutic potentialMolecular Oncology, 2022
- Ppt1‐deficiency dysregulates lysosomal Ca++ homeostasis contributing to pathogenesis in a mouse model of CLN1 diseaseJournal of Inherited Metabolic Disease, 2022
- Thioesterase enzyme families: Functions, structures, and mechanismsProtein Science, 2021
- In a mouse model of INCL reduced S‐palmitoylation of cytosolic thioesterase APT1 contributes to microglia proliferation and neuroinflammationJournal of Inherited Metabolic Disease, 2021
- Functional importance of palmitoyl protein thioesterase 1 (PPT1) expression by Sertoli cells in mediating cholesterol metabolism and maintenance of sperm qualityMolecular Reproduction and Development, 2019
- Cln3‐mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl‐protein thioesterases‐1 (Ppt1)‐protein and Ppt1‐enzyme activity in the lysosomeJournal of Inherited Metabolic Disease, 2019
- Fyn inhibition rescues established memory and synapse loss in Alzheimer miceAnnals of Neurology, 2015
- Palmitoyl‐protein thioesterase 1 (PPT1): An obesity‐induced rat testicular marker of reduced fertilityMolecular Reproduction and Development, 2013
- Lysosomal impairment in Parkinson's diseaseMovement Disorders, 2013
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinosesHuman Mutation, 2011